je.st
news
BerGenBio presents promising therapeutic candidate in AML at ASCO
2013-06-03 08:23:44| Logistics - Topix.net
BerGenBio AS, an emerging oncology biopharma company, has presented data on the importance of the receptor tyrosine kinase, Axl, in acute myeloid leukemia at the ASCO Annual Meeting 2013, in Chicago, IL.
Tags: presents
candidate
therapeutic
promising
Category:Transportation and Logistics